NEWS&VIEWS 19 LabVantage Expands EU Presence
Sartorius and TEWS Elektronik Sign Agreement
Sartorius, has signed an agreement covering sales, marketing and servicing of microwave resonance analysers for the food and pharma industries with Hamburg-based measuring equipment supplier TEWS Elektronik. The range of applications for these instruments includes rapid and precise moisture content monitoring and the associated quality assurance and optimisation of raw, intermediate and end products, the company said.
From left to right: Claudio Tovani, Paolo Concio, Sofia Colombo, Sergio Nasi, Luigi Colombo & Vitale Ambrosini
LabVantage has announced the opening of its new office in Monza, Italy. Located northeast of the capital city of Milan, Monza is the third largest city in Lombardy, considered to be one of the most important economic regions of Italy.
"This new office not only serves as the strategic business development centre for the European market, but also enables LabVantage to provide comprehensive training and prompt client services to both our local and regional
customers in EMEA," affirms Paolo Concio, Director of European Sales. He added that a series of on-site training programs offering experience on SQL*LIMS and SAPPHIRE Laboratory Information Management Suite (LIMS) would also be available.
Headquartered in the United States, the company has established a strong direct presence with local domain experts throughout Western Europe.
TO FIND OUT MORE CIRCLE NO. 55 Newsclips
Thermo Fisher Scientific Inc, has extended some of its current LC-MS trade- in programs to include instruments from any vendor. During September scientists are invited to trade in any model of ion trap or triple stage quadrupole mass spectrometer for a discounted price on a new Thermo Scientific linear ion trap or triple stage quadrupole mass spectrometer through the promotional period.
For more information, customers from France, Germany and Spain can visit
www.thermo.com/mstrade. All others can visit
www.thermoscientific.com/mstrade.
Ocean Optics Photo Contest is open to all customers, partners, distributors and advocates of Ocean Optics. This is an opportunity to share experiences and knowledge with the entire world. The most innovative, entertaining and educational submissions will win prizes, including grand prizes for both the Video and Photo Contest, and five honourable mentions.
Entries must be received by October 31, 2010. Entries will be posted periodically, and all will be posted by November 10th. That way, everyone can check out the competition and see their pics and videos live and in action.
For more information please visit
http://www.oceanphotochallenge.com
OctoPlus NV a drug delivery company has signed an agreement with a US biotechnology company relating to the use of OctoPlus' controlled release technology. Under the contract OctoPlus will develop a controlled release version of a product currently in clinical development using its proprietary drug delivery technology PolyActive®
. The client will reimburse OctoPlus
for its activities under the agreement. Further financial terms of the agreement were not disclosed. Simon Sturge, CEO of OctoPlus, said: "I am delighted to see the continued adoption of our PolyActive®
technology. We
continue to explore opportunities where OctoPlus' skills in microsphere development and production can be best exploited."
TO FIND OUT MORE CIRCLE NO. 58
"For Sartorius, this agreement with TEWS Elektronik, a significant company in microwave resonance technology, represents an important extension of our portfolio for our Process Analytics business unit. The
products are a perfect fit with our strategic alignment, aiming to leverage innovative solutions for process-critical parameters that we can offer our customers in the food and pharmaceutical industries,” stated Reinhard Vogt, Executive Vice President of Sales, Marketing and Service at Sartorius.
"This alliance with Sartorius gives us access to an organisation that is able to offer its customers comprehensive applications support alongside a global sales, marketing and service network,” said Andre Tews "We anticipate enhanced market penetration of food and pharma industry sectors relying on quality-critical processes.”
TO FIND OUT MORE CIRCLE NO. Cyprotex Acquires Apredica
Contract Research Organisation Cyprotex which specialises in the preclinical ADME assessment of drug candidates has moved to acquire the issued share capital of Apredica LCL, a US-based CRO specialising in preclinical ADME and Toxicology assessment. Immediately preceding this move, Apredica had acquired the Intellectual Property and all other assets necessary for offering the Cellular Systems Biology (CSB™) and High Content Toxicology services previously offered by Cellumen, Inc.
The total consideration for the acquisition of Apredica is £2.68 million to be satisfied
through a combination of 44,730,297 new Cyprotex shares and £1 million in cash. The transaction was unanimously recommended by the Boards of both Cyprotex and Apredica, and does not require shareholder approval.
The combined organisation has operations in the world’s two largest centres of drug discovery, Europe and North America with little overlap in their customer bases, the company reports. Cyprotex’s entry into the in vitro toxicology market, will soon be further bolstered by the Company’s new toxicology laboratory in Macclesfield, due to open this October.
TO FIND OUT MORE CIRCLE NO. Shire Receives Mediscience Accolade
Shire Plc the global specialty biopharmaceutical company, was named Company of the Year at the European Mediscience Awards 2010 in June in London.
All quoted European mediscience companies are eligible for the European Mediscience Awards, provided that the majority of the business of the company, and its subsidiaries, are in the healthcare, medical, pharmaceutical, biotechnology or life sciences sectors. This numbers over 150 quoted companies.
The award scheme recognises the importance of the capital markets to fund growth and innovation in the biopharmaceutical marketplace. The criteria for the Company of the Year award is a well defined strategy and demonstration of the ability to deliver its key financial, ethical and social ambitions.
Angus Russell, Chief Executive Officer of Shire, commented: “We’re delighted to have been voted Company of the Year at the Mediscience awards. This award recognises the success of our strategy and the hard work of everyone at Shire who is so dedicated to meeting the needs of the patients and their families that rely on Shire medicines.”
On behalf of the voting panel, Kate Silverton, BBC personality and awards presenter, said: “Shire has enjoyed a spectacular year, successfully making an excellent transition from a focus on attention deficit hyperactivity disorders to a genetic disease and specialist biopharmaceutical company.
In financial terms, its 25% increase in 2009 in core product sales underlines its potential in 2010 and beyond.”
TO FIND OUT MORE CIRCLE NO. 59 Biochrom Appoints Group Managing Director
Biochrom Ltd, the UK based subsidiary of Harvard Bioscience Inc, has announced the appointment of Sam Luke as its new Group Managing Director, as the company looks forward to expanding its future potential.
Sam Luke
Commenting on his appointment Sam said: “I am delighted to be back in Cambridge and joining a very
talented team. This is an exciting time to join Biochrom.
Following the recent launch of the new Biochrom Libra range of double beam UV spectrophotometers and new amino acid analysers, we aim to focus on business growth, building on the momentum achieved to date.”
Sam holds an Engineering degree from Clare College, University of Cambridge, UK, and has more than 25 years experience in the instrumentation and measurement market. He spent the last six years as the European General Manager for the customer services division of Agilent Technologies. Prior to that, he held a number of senior positions
in sales and marketing at Agilent Technologies and Hewlett Packard.
HBIO Division President Jeff Cohen welcomed Sam saying: “His wealth of experience, leadership and strong customer focus will be invaluable as Biochrom pursues an active product development programme and expands operations worldwide.”
TO FIND OUT MORE CIRCLE NO. 60 57 56
READ ALL THE LATEST NEWS & VIEWS, ARTICLES AND NEW PRODUCT RELEASES ONLINE, VISIT:
WWW.LABMATE-ONLINE.COM
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68
